For informational and research purposes only.
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Metabolism, recovery and emerging research
A human aging study found lower circulating MOTS-c but higher muscle levels. Separate compartments and unpaired older samples complicate claims of deficiency.
Read articleThe original experiments compared particular hormone responses. Here is what that finding tells us about ipamorelin—and what remains unknown in people.
Read articleRodent dopamine findings, human brain scans and attention are different measurements. Learn what Semax studies actually support about stimulant comparisons.
Read articleWhat salt names, patent stability tests and animal pharmacokinetics can tell you about BPC-157 capsules—and what still needs a human comparison.
Read articleSmall Selank reports describe anxiety improvement. Learn how symptom scales, daily function, comparator treatments and follow-up shape what those findings mean.
Read articleSleepiness, reaction time and cognitive performance are different outcomes. Explore what Selank tolerability reports do and do not establish.
Read articleThymosin beta-4 has shown different effects across cancer models. Learn what overexpression, cell-exposure and mouse studies can say about human safety.
Read articleKisspeptin studies use brain scans to explore sexual responses. Learn what BOLD imaging adds, how the trials worked and why lasting benefit is a separate question.
Read articleResearch schedules help identify a treatment worth testing further. They don't establish a personal starting dose, conversion or combination protocol.
Read articleSeparate CJC-1295 exposure from GH secretion and IGF-1 response, including the human pulse study and the limits of timing-based treatment claims.
Read articleThe diabetes trial planned HbA1c as a primary outcome. Its small changes, lipid findings and follow-up still leave important treatment questions open.
Read articleA closer look at the people, placebo comparisons and sleep measurements behind the conflicting older DSIP reports.
Read article241–252 of 323 articles
